Publications: all consultations

You can use the filters to show only results that match your interests

Filter publications
34 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Strategy for pharmacopoeial public quality standards for biological medicines

    • MHRA
    • Consultation outcome
  2. Proposal to make Dovonex Psoriasis Ointment available from Pharmacies

    • MHRA
    • Consultation outcome
  3. Proposal to make Arthriex 750mg and 1500mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  4. Classification of Nasonex Allergy Control Nasal Spray

    • MHRA
    • Consultation outcome
  5. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

    • MHRA
    • Consultation outcome
  6. Proposal to make Maloff Protect 250mg/100mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  7. Post-implementation Review of the Human Medicines Regulations 2012 (MLX 391)

    • MHRA
    • Closed consultation
  8. Proposal to make Sildenafil 50mg film-coated tablets available from Pharmacies

    • MHRA
    • Closed consultation
  9. Proposal on increases and additions to current medical devices fees

    • MHRA
    • Consultation outcome
  10. Pharmacy dispensing models and displaying prices on medicines

    • DH and MHRA
    • Closed consultation
  11. Regulatory fees for e-cigarettes

    • MHRA
    • Consultation outcome
  12. Classification of Ibuprofen Seven Plus 200mg/5ml Oral Suspension

    • MHRA
    • Closed consultation
  13. Regulatory fees for medicines: 2016 to 2017 and fees for online sellers of medicines

    • MHRA
    • Consultation outcome
  14. Proposal to allow wider access to naloxone for use in emergencies

    • MHRA
    • Closed consultation
  15. British Pharmacopoeia Commission: triennial review

    • DH and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  16. Commission on Human Medicines: triennial review

    • DH, MHRA and CHM
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  17. Hormonal pregnancy tests: call for evidence

    • MHRA
    • Closed consultation
  18. Classification of Nexium Control 20mg Gastro-Resistant

    • MHRA
    • Consultation outcome
  19. Allowing paramedics involved in helicopter search and rescue operations to administer medicines

    • MHRA
    • Closed consultation
  20. Amendments to the Human Medicines Regulations 2012

    • DH and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  21. Reclassify Soleve Sunburn Relief cutaneous emulsion

    • MHRA
    • Closed consultation
  22. Transfer of responsibility of the certificate of free sales (CFS) to MHRA

    • MHRA
    • Consultation outcome
  23. Proposal to simplify the information requirements for advertising of medicinal products to prescribers and suppliers of medicines (MLX384)

    • MHRA
    • Consultation outcome
  24. Supplying asthma inhalers to schools for emergency use

    • DH and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  25. Safety feature (Falsified Medicines Directive): ‘black’ and ‘white’ lists

    • MHRA
    • Closed consultation
  26. Plans to revoke ‘The Clinical Thermometers Regulations 1993’

    • MHRA
    • Closed consultation
  27. MHRA business engagement assessment - variations processing review

    • MHRA
    • Consultation outcome
  28. Change in classification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets (ARM 87)

    • MHRA
    • Closed consultation
  29. Change in legal classification of Nurofen Express 400mg Oral Powder (ARM 86)

    • MHRA
    • Closed consultation
  30. MHRA business engagement assessment on introduction of tell-and-do variations for a specific subset of parallel import licences

    • MHRA
    • Closed consultation
  31. Availability of diclofenac as a pharmacy medicine (MLX 382)

    • MHRA
    • Closed consultation
  32. European Commission's proposal for pharmacovigilance fees payable to the European Medicines Agency

    • DH and MHRA
    • Closed consultation

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  33. Proposal to end sell-through period for unlicensed herbal medicines

    • MHRA
    • Consultation outcome
  34. Classification of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

    • MHRA
    • Consultation outcome